CN Patent

CN108653216B — 注射用替加环素

Assigned to Fuan Pharmaceutical Group Hubei People's Pharmaceutical Co ltd · Expires 2020-12-18 · 5y expired

What this patent protects

本发明公开了一种注射用替加环素。它由替加环素和注射级乳糖组成；规格50mg；替加环素50.0mg，配方组分为：注射级乳糖100.0mg，注射用水加至2.5g；pH值为4.0～6.0。本发明具有质量稳定、可控，单杂、总杂较少的优点。

USPTO Abstract

本发明公开了一种注射用替加环素。它由替加环素和注射级乳糖组成；规格50mg；替加环素50.0mg，配方组分为：注射级乳糖100.0mg，注射用水加至2.5g；pH值为4.0～6.0。本发明具有质量稳定、可控，单杂、总杂较少的优点。

Drugs covered by this patent

Patent Metadata

Patent number
CN108653216B
Jurisdiction
CN
Classification
—
Expires
2020-12-18
Drug substance claim
No
Drug product claim
No
Assignee
Fuan Pharmaceutical Group Hubei People's Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.